Our study uncovers a distinctive facet of tumorigenesis by identifying a previously unknown positive-feedback loop in the STAT3–TINCR–EGFR signaling pathway; this suggests that the feedback loop could represent a new therapeutic target in pharmacological strategies developed for human cancers. This evidence concerns the gene EGFR and cancer.